![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07F 9/6561 | (2006.01) |
C07F 9/65616 | (2013.01) | ||
A61K 31/52 | (2006.01) | ||
A61P 31/12 | (2018.01) | ||
A61P 31/12 | (2006.01) | ||
A61P 31/00 | (2018.01) | ||
A61K 31/675 | (2013.01) | ||
A61K 45/06 | (2013.01) |
(11) | Number of the document | 3503895 |
(13) | Kind of document | T |
(96) | European patent application number | 17844238.0 |
Date of filing the European patent application | 2017-08-22 | |
(97) | Date of publication of the European application | 2019-07-03 |
(45) | Date of publication and mention of the grant of the patent | 2021-09-15 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2017/047892 |
Date | 2017-08-22 |
(87) | Number | WO 2018/039157 |
Date | 2018-03-01 |
(30) | Number | Date | Country code |
201662379455 P | 2016-08-25 | US |
(72) |
DA COSTA, Daniel , FR
DOUSSON, Cyril, B. , FR
DUKHAN, David , FR
PAPARIN, Jean-Laurent , FR
RAHALI, Houcine , FR
RAHEEM, Izzat , US
|
(73) |
Merck Sharp & Dohme Corp. ,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
Idenix Pharmaceuticals LLC , 320 Bent Street, Cambridge, MA 02141, US |
(54) | ANTIVIRAL PRODRUGS OF TENOFOVIR |
ANTIVIRAL PRODRUGS OF TENOFOVIR |